Advertisement

Topics

Protalex Significantly Strengthens Global Intellectual Property Portfolio for Proprietary Immunomodulatory Therapeutic

08:00 EDT 13 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Granted Six Key International Patents Protecting and Expanding Use for PRTX-100 Protalex, Inc. (OTCQB:PRTX), a clinical-stage biopharmaceutical company, announces that the Company has been granted several key patents for ...

Other Sources for this Article

LHA
Anne Marie Fields, 212-838-3777
afields@lhai.com

NEXT ARTICLE

More From BioPortfolio on "Protalex Significantly Strengthens Global Intellectual Property Portfolio for Proprietary Immunomodulatory Therapeutic"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...